Protez Pharmaceuticals, Inc. discovers, develops, and commercializes antibiotics for difficult-to-treat hospital-based infections.
Business Model:
Revenue: $0
Employees: 1-10
Protez Pharmaceuticals was acquired by
Novartis.
The acquisition happend on 2008-06-01.
Details of the transaction were not public
Address:
City: Malvern
State: Pennsylvania
Zip:
Country: United States
Protez Pharmaceuticals is a medical research company that discovers, develops, and commercializes antibiotics for difficult-to-treat hospital-based infections. The company focuses on differentiated intravenous and oral small molecule antibiotics to address bacterial resistant, and chronic or recurrent infections. Protez Pharmaceuticals was founded by Christopher M. Cashman in 2003 and is headquartered in Malvern, Pennsylvania.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2005 | Series B | 5 | $15M |
Bay City Capital BioAdvance Birchmere Ventures L Capital Partners SR One Bay City Capital BioAdvance Birchmere Ventures L Capital Partners SR One |
2/2004 | Series A | 1 | - |
BTG International BTG International |
6/2004 | Venture Round | 1 | - |
BioAdvance BioAdvance |
6/2004 | Venture Round | 1 | - |
BioAdvance BioAdvance |
2/2004 | Series A | 1 | - |
BTG International BTG International |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|